Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Wealth and urbanization shape medium and large terrestrial mammal communities.
Magle SB, Fidino M, Sander HA, Rohnke AT, Larson KL, Gallo T, Kay CAM, Lehrer EW, Murray MH, Adalsteinsson SA, Ahlers AA, Anthonysamy WJB, Gramza AR, Green AM, Jordan MJ, Lewis JS, Long RA, MacDougall B, Pendergast ME, Remine K, Simon KC, St Clair CC, Shier CJ, Stankowich T, Stevenson CJ, Zellmer AJ, Schell CJ. Magle SB, et al. Among authors: gramza ar. Glob Chang Biol. 2021 Nov;27(21):5446-5459. doi: 10.1111/gcb.15800. Epub 2021 Aug 17. Glob Chang Biol. 2021. PMID: 34405496
A phase II study of tarloxotinib (a hypoxia activated prodrug of a pan-erb tyrosine kinase inhibitor) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or skin.
McLean LS, Morris TA, Gramza A, Liu S, Khan SA, Colevas AD, Pearce T, Rischin D. McLean LS, et al. Among authors: gramza a. Invest New Drugs. 2022 Aug;40(4):782-788. doi: 10.1007/s10637-022-01230-w. Epub 2022 Apr 18. Invest New Drugs. 2022. PMID: 35435625 Clinical Trial.
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.
Del Rivero J, Donahue RN, Marté JL, Gramza AW, Bilusic M, Rauckhorst M, Cordes L, Merino MJ, Dahut WL, Schlom J, Gulley JL, Madan RA. Del Rivero J, et al. Among authors: gramza aw. Front Endocrinol (Lausanne). 2020 Aug 7;11:490. doi: 10.3389/fendo.2020.00490. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32849281 Free PMC article.
Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
Writing Group for the TRIGR Study Group; Knip M, Åkerblom HK, Al Taji E, Becker D, Bruining J, Castano L, Danne T, de Beaufort C, Dosch HM, Dupre J, Fraser WD, Howard N, Ilonen J, Konrad D, Kordonouri O, Krischer JP, Lawson ML, Ludvigsson J, Madacsy L, Mahon JL, Ormisson A, Palmer JP, Pozzilli P, Savilahti E, Serrano-Rios M, Songini M, Taback S, Vaarala O, White NH, Virtanen SM, Wasikowa R. Writing Group for the TRIGR Study Group, et al. JAMA. 2018 Jan 2;319(1):38-48. doi: 10.1001/jama.2017.19826. JAMA. 2018. PMID: 29297078 Free PMC article. Clinical Trial.
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM; TRIGR Study Group. Knip M, et al. JAMA. 2014 Jun 11;311(22):2279-87. doi: 10.1001/jama.2014.5610. JAMA. 2014. PMID: 24915259 Free PMC article. Clinical Trial.
25 results